Isu Chemical Co Ltd (005950) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Isu Chemical Co Ltd stock KRW 1,238, price KRW 8,170, that is 84.8% below the price, quality 32 out of 100. Rating: strongly overvalued. Calculated from audited financials with 4 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 6, 2026.
How to read this chart
60‑month range 4,975 KRW – 69,492 KRW · fair‑value band 1,238 KRW – 2,404 KRW · the 8,170 KRW price screens above the 1,238 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 6, 2026.
Follow Isu Chemical Co in your weekly email
Every Wednesday you see whether Isu Chemical Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
ISU Chemical Co., Ltd. produces and sells petrochemicals and green bio chemicals in South Korea. Its products include linear alkyl benzene, NP, parasol, D-Sol, TAB, IPA, TDM, NOM, and NDM products. The company was founded in 1969 and is headquartered in Seoul, South Korea.
Stock analysis
Isu Chemical Co Ltd (005950) currently trades at 8,170 KRW, while our model-based Fair Value estimate is 1,238 KRW, 85% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Economic Profit group reads highest at a median of 2,711 KRW per share, and 0 of the 4 models we run sit above the 8,170 KRW price.
Bear case: the Multiples group reads lowest at 479.54 KRW, and 4 of the 4 models stay below the price. Data coverage for this calculation is low.
Scenario range: 1,238 KRW (bear) to 2,404 KRW (bull), the price of 8,170 KRW sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 32/100 (below-average quality), in the Basic Materials sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Isu Chemical Co Ltd reported revenue of 1.7T KRW in FY2025 versus 1.7T KRW in FY2021, a compound −0.7%/yr. Reported net income was −31.1B KRW in FY2025.
Key figures
Market cap 215B KRW (≈ $159M) Micro · P/E ratio 2.7 · P/S ratio 0.09 · EPS (TTM) 3,233 KRW · Net margin 3.7% · Return on equity 23.8% · Return on assets (EBIT) −0.4% (5-year average) · Operating margin 13.0%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 35 out of 100 (medium confidence).
What moves the price
The share trades about 51% below its 52-week high and 14% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −25% fair-value upside, at −85%, 005950 screens richer than that median.
Fair Value models
Bear1,238 KRWFair Value 1,238 KRWBull2,404 KRW
Price 8,170 KRW · Downside -84.8%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (2,772 KRW per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
EPV2,563 KRW2,711 KRW2,828 KRW74
ROIC Compounder2,563 KRW2,711 KRW2,828 KRW72
EV/EBITDAn/a479.54 KRW>1,918 KRW62
All 4 models by family
Earnings-Based
EPV2,563 KRW2,711 KRW2,828 KRW74
Multiples
EV/EBITDAn/a479.54 KRW>1,918 KRW62
Asset-Based
NCAV (Graham)1,087 KRW1,456 KRW2,174 KRW54
Economic Profit
ROIC Compounder2,563 KRW2,711 KRW2,828 KRW72
The fair value above starts from this blend and is adjusted for dilution from new shares.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.35/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−13.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−6.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.7%
Start year 2020 (pandemic). Over 10 years: +1.2% a year
Revenue growth 25 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.8%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−2.3% (2020) → 0.7% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Chemicals · 336 stocks
Beats the industry median on 6/12 measures
A mixed picture versus its industry peers.
Valuation
Quality Score32 · Bottom 25%
Fair Value upside−84.8% · Bottom 25%
Profitability
Return on equity (12 months)23.8% · Top 25%
Return on assets−3.5% · Bottom 25%
Net margin (12 months)3.7% · Below median
Operating margin (12 months)13.0% · Above median
Growth and dividend
Revenue growth (quarter YoY)118.8% · Top 25%
Balance sheet
Debt / equity0.48× · Highest 25%
Valuation Multiplesvs Chemicals median · lower = cheaper
P/E (12 months)2.7× · Cheapest 25%
P/B2.24× · Pricier than median
P/S (12 months)0.09× · Cheapest 25%
EV/EBITDA1.3× · Cheapest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 8
FUTURE (revenue growth)100· sector 69
PAST (return on equity)95· sector 24
HEALTH (low debt)76· sector 94
DIVIDEND (yield)0· sector 32
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Isu Chemical Co Ltd Fair Value". https://www.fairvalue-calculator.com/stock/005950
Frequently asked questions
Is Isu Chemical Co Ltd (005950) overvalued or undervalued?
As of Nov 6, 2026, our model estimates a fair value of 1,238 KRW versus a price of 8,170 KRW, about 85% lower (overvalued).
What is the fair value of 005950?
Our model-based fair value for Isu Chemical Co Ltd is 1,238 KRW (as of Nov 6, 2026), built from audited fundamentals. The current price: 8,170 KRW.
What is the quality score of 005950?
Isu Chemical Co Ltd has a Quality Score of 32/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Isu Chemical Co Ltd (005950)?
Our model-based price target is the fair value of 1,238 KRW (as of Nov 6, 2026) from 4 valuation models. Cautious scenario 1,238 KRW, optimistic scenario 2,404 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Isu Chemical Co Ltd stock forecast for 2026?
Our models put fair value at 1,238 KRW, about 85% lower versus a price of 8,170 KRW (overvalued). Cautious scenario 1,238 KRW, optimistic scenario 2,404 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Isu Chemical Co Ltd (005950)?
Isu Chemical Co Ltd reported trailing-twelve-month revenue of about 2.3T KRW (latest available figure, as of Nov 6, 2026).
What is the intrinsic value of Isu Chemical Co Ltd (005950)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Isu Chemical Co Ltd it is 1,238 KRW per share (as of Nov 6, 2026), against a price of 8,170 KRW. It is the blended result of 4 valuation models in 4 families (Earnings-Based, Multiples, Asset-Based, Economic Profit).
Is Isu Chemical Co Ltd stock overvalued or undervalued in 2026?
As of Nov 6, 2026, 005950 trades above its calculated fair value: price 8,170 KRW, fair value 1,238 KRW, a gap of about −85% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 005950?
No. The price is what the market pays today (8,170 KRW); the fair value is what the company's own numbers justify (1,238 KRW). For Isu Chemical Co Ltd the two are 6,932 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Isu Chemical Co Ltd worth?
The market values Isu Chemical Co Ltd at about 215B KRW (market capitalisation, as of Nov 6, 2026). Per share that is 8,170 KRW; our models calculate a fair value of 1,238 KRW per share.
What do the bullish and bearish scenarios say about 005950?
Our models span a range for Isu Chemical Co Ltd: cautious scenario 1,238 KRW, base 1,238 KRW, optimistic 2,404 KRW per share (as of Nov 6, 2026, price 8,170 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 005950?
Isu Chemical Co Ltd trades at a price-to-earnings ratio of 2.7 (as of Nov 6, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 1,238 KRW is built from several models across several years. Other multiples: P/B 2.2, P/S 0.1, EV/EBITDA 1.3.
How solid is the balance sheet of Isu Chemical Co Ltd (005950)?
Balance-sheet figures for Isu Chemical Co Ltd (as of Nov 6, 2026): return on equity 23.8%, debt of 0.48 per unit of equity. They feed the Quality Score of 32/100, which measures business quality independently of the share price.
How far is 005950 from its 52-week high?
Isu Chemical Co Ltd trades at 8,170 KRW, about 51% below its 52-week high of 16,700 KRW and 14% above the low of 7,160 KRW (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 1,238 KRW is for.
Which stocks are comparable to Isu Chemical Co Ltd?
From the same area (Basic Materials) we also value BASF SE, Saudi Basic Industries Corporation, Dow Inc, Ningxia Baofeng Energy Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Isu Chemical Co Ltd stock attractive at the current price?
The data as of Nov 6, 2026: price 8,170 KRW, calculated fair value 1,238 KRW (−85%), Quality Score 32/100, from 4 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 005950 calculated?
We run Isu Chemical Co Ltd through 4 models from 4 families: Earnings-Based, Multiples, Asset-Based, Economic Profit. Every model gets the same audited fundamentals; the fair value of 1,238 KRW builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Isu Chemical Co Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Isu Chemical Co Ltd (005950)?
The closing price on Nov 6, 2026 was 8,170 KRW. Our model-based fair value is 1,238 KRW, about 85% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Isu Chemical Co Ltd right now?
The price sits above even our optimistic bull case (2,404 KRW). The favourable scenario is already priced in. Weak quality (32/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (1,238 KRW to 2,404 KRW) leaves room in how you read the outcome.
Key figures of Isu Chemical Co Ltd
How large is the market capitalisation of Isu Chemical Co Ltd (005950)?
The market capitalisation of Isu Chemical Co Ltd is 215B KRW (≈ $159M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Isu Chemical Co Ltd (005950)?
The price-to-sales ratio of Isu Chemical Co Ltd is 0.09 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Isu Chemical Co Ltd (005950)?
Earnings per share at Isu Chemical Co Ltd are 3,233 KRW (price ÷ EPS = P/E 2.7). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Isu Chemical Co Ltd (005950)?
The net margin of Isu Chemical Co Ltd is 3.7% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Isu Chemical Co Ltd (005950)?
The return on equity (ROE) of Isu Chemical Co Ltd is 23.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Isu Chemical Co Ltd (005950)?
On an EBIT basis the return on assets of Isu Chemical Co Ltd is −0.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Isu Chemical Co Ltd (005950)?
The operating margin of Isu Chemical Co Ltd is 13.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Isu Chemical Co Ltd (005950)?
Revenue at Isu Chemical Co Ltd is growing +119% versus a year earlier (3y avg −6.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Isu Chemical Co Ltd (005950)?
Earnings per share at Isu Chemical Co Ltd are growing −15.7% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Isu Chemical Co Ltd (005950) generate?
The free cash flow of Isu Chemical Co Ltd is −32.3B KRW (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Isu Chemical Co Ltd (005950) carry?
The net debt of Isu Chemical Co Ltd is 350B KRW (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Isu Chemical Co Ltd in the live analysis
One click puts Isu Chemical Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 6, 2026